Pasithea Therapeutics Corp. (KTTAW) Total Liabilities (2020 - 2026)

Pasithea Therapeutics has disclosed Total Liabilities across 7 years of filings, most recently posting $1.9 million for Q2 2026.

• In Q2 2026, Total Liabilities rose 2.16% year-over-year to $1.9 million; the TTM figure through Jun 2026 stood at $1.9 million (up 2.16% YoY), while the FY2025 annual figure was $5.0 million, up 291.63% from the prior year.
• Total Liabilities came in at $1.9 million for Q2 2026 at Pasithea Therapeutics, up from $1.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $5.0 million in Q4 2025 to a low of $823975.0 in Q3 2024.
• Average Total Liabilities over 5 years is $2.1 million, with a median of $1.9 million recorded in 2025.
• Year-over-year, Total Liabilities jumped 430.62% in 2022 and sank 63.92% in 2024.
• Over 5 years, Total Liabilities stood at $2.7 million in 2022, then advanced by 1.36% to $2.7 million in 2023, then tumbled by 52.84% to $1.3 million in 2024, then jumped by 291.63% to $5.0 million in 2025, then plunged by 62.75% to $1.9 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $1.9 million in Q2 2026, $1.5 million in Q1 2026, and $5.0 million in Q4 2025.